Santé publique et sciences de la vie

Nous travaillons avec le milieu médical à transformer la vie des patients en le dotant des meilleurs dirigeants et des meilleurs talents disponibles dans le monde entier.

Sous-sections

Fournisseurs de médicaments en vente libre, institutions de recherche privées, fabricants d'appareillages et autres acteurs du secteur des sciences de la vie profitent de l'expertise spécialisée de Boyden dans ce domaine particulier.

Diane Turek Pire

Associée, Summit

Gary Kastenbaum

Associé directeur, Summit

Articles et publications

ESG in Biotech: Paving the Way for a Sustainable Future

The impact of ESG investing is too significant to ignore and with the battle for funds at its peak, the biotech industry needs to be at the forefront of the agenda. With impending mandates, the pressure is firmly on businesses to start thinking about their ESG proposition and how it may positively influence and affect the wider industry.

Articles et publications

Talent-led transformation in a post-pandemic world: Latin America

How can global business leaders deliver on ambitions of growth and reinvention?

Resilient Leadership

Accelerating Innovation - The Crisis Factor

An interview with Alistair Kirk, transformation programme expert and member of the UK’s Vaccine Taskforce.

Perspectives de l'industrie

Google in the Digital Health Arena

Google is making a push into digital health, including the use of artificial intelligence to analyse patient data, stoking concerns about privacy.

Communiqués de presse

Boyden’s US Growth Continues with Marquee Hires Dorothy Billingsly and Keith Dorsey

Senior advisors and business academics in healthcare, professional services and corporate governance bring unique expertise to clients

This website uses cookies to ensure you get the best experience on our website. Learn more